Johnson & Johnson (NYSE:JNJ) decided to discontinue the Phase 3 VENTURA development program evaluating aticaprant, a kappa ...
A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.
Analysts do not believe the Phase III stumble for aticaprant will derail J&J’s broader neuroscience strategy, particularly ...
Johnson & Johnson's Spravato therapy for treatment ... the drugmaker added to the evidence behind Spravato – an intranasal formulation of esketamine – with the release of top-line data from ...
NHS patients with treatment-resistant depression in Scotland will be able to access Johnson & Johnson’s ... border – backed the use of Spravato (esketamine) nasal spray at its meeting this ...
After I have presented the key tasks I faced when creating "ALLKA 4D Rating", I will move on to comparing Johnson & Johnson and Pfizer and choose the winner in the category "the most promising ...
Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a ...
Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing ...
House Speaker Mike Johnson addressed the “shameful” behavior several Democratic lawmakers showcased at President Donald Trump’s address to Congress, during which these lawmakers “missed ...
Jessica Simpson drags her estranged husband, Eric Johnson, in her emotional new song, “Leave,” after announcing their separation. The pop star suggests the former NFL player cheated on her ...
House Speaker Mike Johnson on Saturday unveiled a short-term funding bill that would keep federal agencies funded through September and fend off the looming government shutdown. The 99-page ...
Colorado added Erik Johnson from the Philadelphia Flyers for Givani Smith. Sportsnet first reported the deal shortly after the 1 p.m. deadline. Johnson played 717 of his 1,009 career games during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results